<DOC>
	<DOCNO>NCT02309268</DOCNO>
	<brief_summary>The purpose research monitor well patient surgery treatment leave atrial appendage ( LAA ) .</brief_summary>
	<brief_title>Atrial Appendage Closure Prospective Observational Study</brief_title>
	<detailed_description>Patients follow observational study . We propose single follow-up TEE 3 6 month ( standard care ) confirm LAA ( leave atrial appendage ) occlusion . The TEE mandatory ( clinical trial ) , strongly recommend patient confirm efficacy treatment . This help confirm whether patient may safely remain anticoagulation . The risk TEE le 1 1000 risk death , 1 % less risk major complication , esophageal perforation .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients Atrial fibrillation Are poor candidate take warfarin Have elect undergo LARIAT procedure</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>leave atrial appendage closure</keyword>
</DOC>